Evidence map›Paper›PMID 34440577›Full record

ReviewLife (Basel, Switzerland)2021

Space Radiation Protection Countermeasures in Microgravity and Planetary Exploration.

Carlos A Montesinos, Radina Khalid, Octav Cristea, Joel S Greenberger, Michael W Epperly, Jennifer A Lemon, Douglas R Boreham, Dmitri Popov, Gitika Gorthi, Nandita Ramkumar and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Carlos A MontesinosNugevity Health Sciences, Houston, TX 77450, USA.ORCID 0000-0002-4859-8772
Radina KhalidSchool of Engineering, Rice University, Houston, TX 77005, USA.
Octav CristeaDepartment of Surgery, Emory University School of Medicine, Atlanta, GA 30322, USA.
Joel S GreenbergerDepartment of Radiation Oncology, University of Pittsburg Medical Center, Pittsburgh, PA 15213, USA.
Michael W EpperlyDepartment of Radiation Oncology, University of Pittsburg Medical Center, Pittsburgh, PA 15213, USA.
Jennifer A LemonMedical Sciences Division, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada.
Douglas R BorehamMedical Sciences Division, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada.
Dmitri PopovAdvanced Medical Technologies and Systems Inc., Richmond Hill, ON L4B 1N1, Canada.
Gitika GorthiIgnited Thinkers, Fairfax, VA 22030, USA.ORCID 0000-0002-2645-6503
Nandita RamkumarCenter for Space Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Jeffrey A JonesCenter for Space Medicine, Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-3059-6832
Baylor College of Medicine · USNOSM University · CAPittsburg State University · USEmory University · USRice University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpace radiation is one of the principal environmental factors limiting the human tolerance for space travel, and therefore a primary risk in need of mitigation strategies to enable crewed exploration of the solar system.

methodsWe summarize the current state of knowledge regarding potential means to reduce the biological effects of space radiation. New countermeasure strategies for exploration-class missions are proposed, based on recent advances in nutrition, pharmacologic, and immune science.

resultsRadiation protection can be categorized into (1) exposure-limiting: shielding and mission duration; (2) countermeasures: radioprotectors, radiomodulators, radiomitigators, and immune-modulation, and; (3) treatment and supportive care for the effects of radiation. Vehicle and mission design can augment the overall exposure. Testing in terrestrial laboratories and earth-based exposure facilities, as well as on the International Space Station (ISS), has demonstrated that dietary and pharmacologic countermeasures can be safe and effective. Immune system modulators are less robustly tested but show promise. Therapies for radiation prodromal syndrome may include pharmacologic agents; and autologous marrow for acute radiation syndrome (ARS).

conclusionsCurrent radiation protection technology is not yet optimized, but nevertheless offers substantial protection to crews based on Lunar or Mars design reference missions. With additional research and human testing, the space radiation risk can be further mitigated to allow for long-duration exploration of the solar system.

Indexed as

bioeffectschromosomal aberrationscountermeasuresimmunologyLunar/Mars explorationnutritionradioprotectionsolar particle eventspace radiation

Identifiers

PMID34440577
PMCPMC8398261
OpenAlexW3195423287

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.